AVENTIX PFX System (PFX01); NOVOCLEAR Device (CLR001)— 510(k) K260255

Substantially Equivalent

Aventix Medical, Inc.

FDA 510(k) clearance K260255 for AVENTIX PFX System (PFX01); NOVOCLEAR Device (CLR001), Substantially Equivalent on 2026-03-27. Applicant: Aventix Medical, Inc..

Clearance details

Applicant: Aventix Medical, Inc.
Product code: Code GEI
Advisory panel: General, Plastic Surgery
Date received: 2026-01-28
Decision date: 2026-03-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Laguna Hills, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code GEI

product code GEI

Death: 133
Injury: 7,585
Malfunction: 35,808
Other: 44
Total: 43,570

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.